Description

Urdamycin D CAS NO 104443-44-9 is a specialized anthracycline-type natural product belonging to the urdamycin family of antibiotics. This compound is of significant interest in pharmaceutical research and development due to its potent biological activity, primarily as an antitumor and antibacterial agent. It is a critical intermediate and reference standard for researchers in the fields of oncology, microbiology, and medicinal chemistry. Key industries requiring this high-purity compound include pharmaceutical R&D, biotechnology, and academic research institutions focused on novel therapeutic discovery.

Application

• Pharmaceutical Research & Development: Serves as a key reference standard and active pharmaceutical ingredient (API) intermediate in the development of novel anticancer and antibiotic therapies.
• Oncology Studies: Used in in vitro and in vivo research to study its mechanism of action, efficacy, and toxicity profiles against various cancer cell lines.
• Microbiological Research: Employed in studies targeting Gram-positive bacteria, helping to understand and combat antibiotic-resistant strains.
• Medicinal Chemistry: Acts as a lead compound or scaffold for the semi-synthesis of new analogs with improved pharmacological properties.
• Biochemical Assays: Utilized as a precise biochemical tool to investigate DNA intercalation and topoisomerase inhibition processes.
• Academic & Institutional Research: Supplied to universities and research institutes for fundamental studies in natural product chemistry and pharmacology.

Basic Information

Product Name	Urdamycin D
CAS No.	104443-44-9
Molecular Formula	C35H40O13
Molecular Weight	668.69 g/mol
Synonyms	Urdamycin D; Antibiotic Urdamycin D; 5,12-Dideoxy-6-O-methyl-11-deoxy-4-O-(2,6-dideoxy-4-O-methyl-α-L-lyxo-hexopyranosyl)-13-dihydrocarminomycinone; 4-O-(2,6-Dideoxy-4-O-methyl-α-L-lyxo-hexopyranosyl)-5,12-dideoxy-6-O-methyl-11-deoxy-13-dihydrocarminomycinone; (1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-1,5,12-trihydroxy-10-methoxy-6,11-dioxo-3-(tetrahydro-3,4-dihydroxy-5-methoxy-6-methyl-2H-pyran-2-yl)-2-naphthacenecarboxylic acid methyl ester
EINECS	Contact for details

Quality Control

Our Urdamycin D is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity for research applications. Each lot undergoes comprehensive analytical testing including HPLC for purity, spectroscopic identification (NMR, MS), and determination of residual solvents and moisture content. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting all critical quality attributes. We support research compliance with traceable documentation for your regulatory needs.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below in a dry, moisture-free environment. This product is hygroscopic (moisture-sensitive) and light-sensitive. For long-term storage, consider storing under an inert atmosphere. Allow the product to warm to room temperature in a desiccator before opening to prevent condensation.

Specification

Item	Specification
Appearance	Red to orange-red powder
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.